Epilepsy Research Studies
Study Title: A Phase 2 Multicenter Double-Blind Randomized Adjunctive Placebo Controlled Trial to Evaluate the Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures. (Identifier: NCT01866111)
Study Purpose: This study is to evaluate the efficacy of YKP3089 in reducing seizure frequency when compared to baseline in subjects with partial onset seizures not fully controlled despite their treatment with 1 to 3 concomitant anti-epileptic drugs.
Principal Investigator: Imran Ali, M.D.
Study Coordinator: Shekhar Raj, for more information, please call 419-383-4293